The efficacy of regorafenib monotherapy as the third-and later-line treatment for metastatic colorectal cancer: a retrospective study

[Objectives] To investigate the efficacy and safety of regorafenib monotherapy as the third-and later-line treatment for metastatic colorectal cancer. [Methods] This was a retrospective analysis of 32 patients with metastatic colorectal cancer receiving regorafenib monotherapy as the third-and later...

Celý popis

Podrobná bibliografie

Hlavní autoři:	An Tianqi, Song Lijie, Zong Hong, Zhao Ruihua
Médium:	Artigo
Jazyk:	Chinês
Vydáno:	Editorial Office of Journal of Colorectal & Anal Surgery 2022-08-01
Edice:	结直肠肛门外科
Témata:	metastatic colorectal cancer regorafenib efficacy safety
On-line přístup:	https://jcas.gxmuyfy.cn/cn/wqll/paper.html?id=377&cateName=2022%E5%B9%B4%20%E7%AC%AC28%E5%8D%B7%20%E7%AC%AC4%E6%9C%9F
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!